Vascular dementia and Alzheimer's disease: Diagnosis and risk factors

Geriatrics and Aging

Volumn 10, Issue 1, 2007, Pages 36-41

  Levinoff, Elise J ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alzheimer's disease; Dementia; Memory; Stroke; Vascular dementia

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGING; ALZHEIMER DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; HUMAN; HYPERTENSION; INCIDENCE; MEMORY; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK FACTOR; STROKE;

EID: 34247217917     PISSN: 14888408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Patterson C, Gauthier S, Bergman H, et al. The recognition, assessment, and management of dementing disorders: conclusions from the Canadian consensus conference on dementia. Can J Neurol Sci 2001;28:Suppl.1-S3-16.
2. Lindsay J, Sykes E, McDowell I, et al. More than the epidemiology of Alzheimer disease: contributions of the Canadian Study of Health and Aging. Can J Psych 2004;49:83-91.
3. Roman G. Vascular dementia: distinguishing characteristics, treatment and prevention. JAGS 2003;51:S296-304.
4. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease : report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Task force on Alzheimer disease. Neurol 1984;34:939-44.
5. Roman G, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurol 1993;43:250-60.
6. Snowdon DA, Greiner LH, Mortimer J, et al. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 1997;277:813-17.
7. Bowler JV. The concept of vascular cognitive impairment. J Neurol Sci 2002;203-4:11-15.
8. Rockwood K. Vascular cognitive impairment and vascular dementia. J Neurol Sci 2002;203:23-7.
9. Roman GC. Vascular dementia revisited. Diagnosis, pathogenesis, treatments and prevention. Med Clin N A 2002;86:477-99.
10. Hachinski V. Vascular dementia: a radical redefinition. Dementia 1994;5:130-2.
11. Wallin A, Milos V, Sjogren M, et al. Classification and subtypes of vascular dementia. Int Psychoger 2003;15:27-37.
12. Rockwood K, Davis H, MacKnight C, et al. The consortium to investigate vascular impairment of cognition: methods and first findings: Can J Neurol Sci 2003;30:237-40.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1994.
14. World Health Organization [WHO]. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva:WHO, 1993.
15. Kertesz A, Clydesdale S. Neuropsychological deficits in vascular dementia vs Alzheimer disease: Frontal lobe deficits prominent in vascular dementia. Arch Neurol 1994;51:1226-31.
16. Hachinski VC, Iliff LD, Zilkha E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
17. Moroney JT, Bagiella E, Desmond DW, et al. Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias. Neurol 1997;49:1096-1105.
18. Gorelick PB. Risk factors for vascular dementia and Alzheimer disease. Stroke 35;2620-22.
19. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) Trial. Lancet 1998;352:1347-51.
20. Tzourio C, Ander C, Chapman N, et al. Effects of Blood Pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003;163:1069-75.
21. Feigen V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci 2005;151-5.
22. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia and major subtypes of dementia. Mayo Clin Proc 2003;78:1290-1308.
23. Finkel SI. Behavioural and psychologic symptoms of dementia. Clin Ger Med 2003;19:799-824.
24. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695-9.
25. Vasilios P. Hypertension and cognitive function: blood pressure regulation and cognitive function: a review of the literature. Geriatrics 2005;60:20-4.
26. Breteler MM. Vascular involvement in cognitive decline and dementia: epidemiologic evidence from the Rotterdam Study and Rotterdam Scan Study Ann NY Acad Sci 2000;93:457-65.
27. Elias ME, Wolf P, D'Agostino RB, et al. Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidem 1993;138:353-64.
28. Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis and treatment JAGS 2002;50:1431-8.